CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 63.8 CNY -0.13% Market Closed
Market Cap: 7.3B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

Operating Margin
CanSino Biologics Inc

-89.2%
Current
-182%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-89.2%
=
Operating Profit
-667.8m
/
Revenue
748.5m

Operating Margin Across Competitors

Country CN
Market Cap 7.3B CNY
Operating Margin
-89%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 749.7B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.3T DKK
Operating Margin
44%
Country US
Market Cap 372B USD
Operating Margin
28%
Country US
Market Cap 257.3B USD
Operating Margin
34%
Country CH
Market Cap 201.7B CHF
Operating Margin
32%
Country UK
Market Cap 163B GBP
Operating Margin
21%
Country CH
Market Cap 179.6B CHF
Operating Margin
31%
Country US
Market Cap 146B USD
Operating Margin
22%
No Stocks Found

CanSino Biologics Inc
Glance View

Market Cap
7.3B CNY
Industry
Pharmaceuticals

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Intrinsic Value
66.95 CNY
Undervaluation 5%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-89.2%
=
Operating Profit
-667.8m
/
Revenue
748.5m
What is the Operating Margin of CanSino Biologics Inc?

Based on CanSino Biologics Inc's most recent financial statements, the company has Operating Margin of -89.2%.